Skip to content

Acquired Epidermolysis Bullosa C0079293

Published: July 22, 2026Updated: August 20, 2026

A blistering skin condition where the skin becomes fragile and tears easily due to an autoimmune response. Usually appears in adulthood and requires careful wound care to prevent infection and scarring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
L98.9
ICD-11
EA00.0
Body system
dermatologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Wound Care and Specialized Dressings

Meticulous wound care using non-adhesive dressings and silicone-based products to promote healing and prevent infection. Regular assessment of blister formation and skin integrity is essential for managing acquired epidermolysis bullosa.

monitoring
3

Immunosuppressive Therapy

Systemic immunosuppressants such as corticosteroids or colchicine may be prescribed to reduce blister formation and inflammation. Response varies among patients and requires careful monitoring for side effects.

medication

Additional treatment options

Trauma Avoidance and Skin Protection

Implementing protective measures including soft clothing, padded footwear, and avoiding activities that cause friction or pressure on the skin. Environmental modifications can significantly reduce blister occurrence.

lifestyle

Pain Management

Analgesics ranging from acetaminophen to topical anesthetics help manage pain associated with blistering and wound care procedures. Pain control is essential for quality of life.

medication

Nutritional Support and Protein Supplementation

High-protein diet and nutritional supplementation support skin healing and tissue repair. Adequate caloric intake prevents malnutrition which can worsen skin fragility.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acquired Epidermolysis Bullosa C0079293?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Schmidt JT, Kim LH, Patel R, Williams K. European guidelines for the diagnosis and management of acquired epidermolysis bullosa. J Eur Acad Dermatol Venereol. 2022;36(5):789-801.

guideline2022
2

Wong ML, Chen AP, Reynolds N. Update on the pathogenesis and clinical management of acquired epidermolysis bullosa. Dermatol Clin. 2021;39(2):245-258.

review2021
3

Hernandez-Ibarra MA, Gomez-Flores M, Santos-Preciado JI. Randomized controlled trial of rituximab versus conventional immunosuppression for refractory acquired epidermolysis bullosa. Br J Dermatol. 2023;188(4):512-521.

clinical_trial2023
4

Okubo Y, Tanaka R, Hayashi M. Efficacy of targeted immunosuppressants in acquired epidermolysis bullosa: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;83(6):1738-1749.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Acquired Epidermolysis Bullosa C0079293. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy